Champions Oncology Posts $13.5M Revenue, $1.1M Adjusted EBITDA
11 Dec 2024 //
ACCESSWIRE
Champions Oncology to Announce Q2 Financial Results Dec 11, 2024
05 Dec 2024 //
ACCESSWIRE
Champions Oncology Announces Agreement with Weill Cornell Medicine
16 Oct 2024 //
ACCESSWIRE
Champions Oncology Reports $14.1M Revenue, $2.0M Adjusted EBITDA
11 Sep 2024 //
ACCESSWIRE
Champions Oncology Announces First Quarter Results Sept 11
09 Sep 2024 //
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $14.0 Million
18 Jul 2024 //
ACCESSWIRE
Champions Oncology To Report Q4 And Year-End Results On July 18, 2024
12 Jul 2024 //
ACCESSWIRE
Champions, MDC: Partnership For Radiopharmaceutical Development
04 Jun 2024 //
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.0 Million
12 Mar 2024 //
ACCESSWIRE
Champions Oncology`s US Laboratory has Acquired Distinguished CAP Accreditation
07 Mar 2024 //
ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results
06 Mar 2024 //
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $11.6 Million
12 Dec 2023 //
ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results
04 Dec 2023 //
ACCESSWIRE
Champions Oncology`s Operations Site Receives ISO-9001:2015 Accreditation
02 Nov 2023 //
ACCESSWIRE
Champions Oncology Announces the Addition of Brady Davis as President
17 Oct 2023 //
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.6 Million
13 Sep 2023 //
ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results 2023
11 Sep 2023 //
ACCESSWIRE
Champions Oncology Announces Lineup of Speakers at Oncology Symposium
22 Aug 2023 //
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $13.1 Million
24 Jul 2023 //
ACCESSWIRE
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results
20 Jul 2023 //
ACCESSWIRE
Champions Oncology Announces $5M Stock Repurchase Program
05 Apr 2023 //
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.8 Million
15 Mar 2023 //
ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results
13 Mar 2023 //
ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
13 Dec 2022 //
ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results
09 Dec 2022 //
ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
08 Sep 2022 //
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
23 Jul 2022 //
PRESS RELEASE